Gut microbiome as a biomarker of cardiometabolic disorders
Introduction and objective Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Rural Health
2017-09-01
|
Series: | Annals of Agricultural and Environmental Medicine |
Subjects: | |
Online Access: | http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.html |
id |
doaj-f7b698a1e1d24198a763d156d3c2b0c9 |
---|---|
record_format |
Article |
spelling |
doaj-f7b698a1e1d24198a763d156d3c2b0c92020-11-25T02:29:37ZengInstitute of Rural HealthAnnals of Agricultural and Environmental Medicine1232-19661898-22632017-09-0124341642210.26444/aaem/7545675456Gut microbiome as a biomarker of cardiometabolic disordersAnna Gózd-Barszczewska0Maria Kozioł-Montewka1Piotr Barszczewski2Agata Młodzińska3Kinga Humińska4Division of Cardiology with Cardiac Intensive Care Unit, Cardinal Stefan Wyszyński Hospital, Lublin, PolandPope John Paul II State School of Higher Education, Biała Podlaska, PolandChair and Department of Medical Microbiology, Medical University, Lublin, Poland; Division of Gastroenterology, Cardinal Stefan Wyszyński Hospital, Lublin, PolandGenomic Laboratory, DNA Research Centre, Poznań, PolandGenomic Laboratory, DNA Research Centre, Poznań, Poland; Laboratory of High Throughput Technologies, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, PolandIntroduction and objective Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut microbiota composition and atherosclerosis risk factors, so in order that it might be used as a biomarker for coronary artery disease diagnosis. Material and methods The study involved middle-aged men in eastern Poland with central obesity (n=20), subjects with atherosclerosis (n=15) and those with no cardiovascular diseases (n=5). The gut microbiota composition was determined using tag-encoded 16S rRNA gene using Illuminal MiSeq. Data were analyzed with the use of t-test. Results Firmicutes (49.26%) and Bacteroidetes (44.46%) were the dominant Phyla in the middle-aged men in eastern Poland. Subjects with improper levels of total cholesterol were enriched in Prevotella (p=0.03) and decreased level of Clostridium (p=0.02). They also showed a falling tendency in Faecalibacterium (p=0.07). An upward trend was observed in Prevotella (p=0.07) in subjects with improper LDL-C values. Conclusions The study showed that intestinal microbiome is likely to play a role in the pathogenesis of atherosclerosis through its role in lipid metabolism. Bacterial genera of particular importance were Prevotella, Bacteroides, Clostridium, Faecalibacterium. However, further studies involving larger groups of subjects are required to confirm these observations.http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.htmlgut microbiotaatherosclerosislipid disordersmicrobiomecardiovascular diseases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Gózd-Barszczewska Maria Kozioł-Montewka Piotr Barszczewski Agata Młodzińska Kinga Humińska |
spellingShingle |
Anna Gózd-Barszczewska Maria Kozioł-Montewka Piotr Barszczewski Agata Młodzińska Kinga Humińska Gut microbiome as a biomarker of cardiometabolic disorders Annals of Agricultural and Environmental Medicine gut microbiota atherosclerosis lipid disorders microbiome cardiovascular diseases |
author_facet |
Anna Gózd-Barszczewska Maria Kozioł-Montewka Piotr Barszczewski Agata Młodzińska Kinga Humińska |
author_sort |
Anna Gózd-Barszczewska |
title |
Gut microbiome as a biomarker of cardiometabolic disorders |
title_short |
Gut microbiome as a biomarker of cardiometabolic disorders |
title_full |
Gut microbiome as a biomarker of cardiometabolic disorders |
title_fullStr |
Gut microbiome as a biomarker of cardiometabolic disorders |
title_full_unstemmed |
Gut microbiome as a biomarker of cardiometabolic disorders |
title_sort |
gut microbiome as a biomarker of cardiometabolic disorders |
publisher |
Institute of Rural Health |
series |
Annals of Agricultural and Environmental Medicine |
issn |
1232-1966 1898-2263 |
publishDate |
2017-09-01 |
description |
Introduction and objective
Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut microbiota composition and atherosclerosis risk factors, so in order that it might be used as a biomarker for coronary artery disease diagnosis.
Material and methods
The study involved middle-aged men in eastern Poland with central obesity (n=20), subjects with atherosclerosis (n=15) and those with no cardiovascular diseases (n=5). The gut microbiota composition was determined using tag-encoded 16S rRNA gene using Illuminal MiSeq. Data were analyzed with the use of t-test.
Results
Firmicutes (49.26%) and Bacteroidetes (44.46%) were the dominant Phyla in the middle-aged men in eastern Poland. Subjects with improper levels of total cholesterol were enriched in Prevotella (p=0.03) and decreased level of Clostridium (p=0.02). They also showed a falling tendency in Faecalibacterium (p=0.07). An upward trend was observed in Prevotella (p=0.07) in subjects with improper LDL-C values.
Conclusions
The study showed that intestinal microbiome is likely to play a role in the pathogenesis of atherosclerosis through its role in lipid metabolism. Bacterial genera of particular importance were Prevotella, Bacteroides, Clostridium, Faecalibacterium. However, further studies involving larger groups of subjects are required to confirm these observations. |
topic |
gut microbiota atherosclerosis lipid disorders microbiome cardiovascular diseases |
url |
http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.html |
work_keys_str_mv |
AT annagozdbarszczewska gutmicrobiomeasabiomarkerofcardiometabolicdisorders AT mariakoziołmontewka gutmicrobiomeasabiomarkerofcardiometabolicdisorders AT piotrbarszczewski gutmicrobiomeasabiomarkerofcardiometabolicdisorders AT agatamłodzinska gutmicrobiomeasabiomarkerofcardiometabolicdisorders AT kingahuminska gutmicrobiomeasabiomarkerofcardiometabolicdisorders |
_version_ |
1724831984069378048 |